IP Library Granted Patent US 10,591,497
Granted Patent B2
US 10,591,497 · App. 14/723,609 · Granted Mar 17, 2020

Immunoassay for synthetic cannabinoids of the adamantyl indazole/indole-3-carboxamide family

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,591,497
App. No.
14/723,609
Granted
Mar 17, 2020
Kind
B2
Abstract

An immunoassay method for detecting and determining adamantane substituted indazole and indole synthetic cannabinoids is described. Also described are components for use in implementing the method, namely, antibodies, detection agents, solid state devices and kits as well as immunogens used to raise the antibodies.

Claims (24)

1. A polyclonal antibody derived from an immunogen having the structure:

wherein KLH is keyhole limpet hemocyanin;

wherein the polyclonal antibody binds to one or more epitopes of one or more molecules of Structure I′,

wherein X is H or F; Y is N or CH; and Z is H or OH; and wherein the polyclonal antibody has an IC 50 of 0.18 ng/ml for 3-OH-AKB48, 2.08 ng/ml for AKB-48, 2.10 ng/ml for N-(5-fluoropentyl)-AKB48 and 4.40 ng/ml for 3-OH-SDB001, and <1.00% cross-reactivity with AKB48 N-Pentanoic acid compared to 100% cross-reactivity with AKB48,

wherein the IC 50 values and cross-reactivity are determined by employing a tracer having the structure:

wherein HRP is horseradish peroxidase.

2. A solid state device supporting the polyclonal antibody of claim 1 .

3. The solid state device of claim 2 which is a biochip or a microtitre plate.

4. A kit for the detection or determination of compounds of Structure I′,

wherein X is H or F; Y is N or CH; and Z is H or OH, comprising the polyclonal antibody of claim 1 .

5. An immunoassay method for detecting or determining compounds of Structure I′

wherein X is H or F; Y is N or CH; and Z is H or OH;

the method comprising

contacting a solution or an in vitro sample taken from an individual suspected of containing compounds of Structure I′ with the polyclonal antibody of claim 1 ; and

one or more detecting agents;

measuring the signal produced by the one or more detecting agent; and

deducing from a calibrator the presence of, or amount of, compounds of Structure I′.

6. The immunoassay method of claim 1 wherein the detecting agent comprises:

7. A method of making an antibody comprising:

administering an immunogen having the structure of:

wherein KLH is keyhole limpet hemocyanin,

to a mammal; and

purifying the resultant antibody.

8. The method of claim 7 , wherein the antibody is a polyclonal antibody.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVENYANCE PREVIOUSLY RECORDED AT REEL: 055950 FRAME: 0471. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 20, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 056210/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 055950/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2018
From: MCCONNELL, IVAN; BENCHIKH, ELOUARD; LOWRY, PHILIP; FITZGERALD, PETER
To: RANDOX LABORATORIES LTD.
Reel/Frame 046375/0961 →